US20050004641A1 - Cardiac stimulating apparatus having a blood clot filter and atrial pacer - Google Patents

Cardiac stimulating apparatus having a blood clot filter and atrial pacer Download PDF

Info

Publication number
US20050004641A1
US20050004641A1 US10/897,504 US89750404A US2005004641A1 US 20050004641 A1 US20050004641 A1 US 20050004641A1 US 89750404 A US89750404 A US 89750404A US 2005004641 A1 US2005004641 A1 US 2005004641A1
Authority
US
United States
Prior art keywords
apparatus according
stimulator
cardiac stimulating
stimulating apparatus
adapted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/897,504
Inventor
Ramesh Pappu
Original Assignee
Ramesh Pappu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US29568301P priority Critical
Priority to US10/163,021 priority patent/US6941169B2/en
Application filed by Ramesh Pappu filed Critical Ramesh Pappu
Priority to US10/897,504 priority patent/US20050004641A1/en
Publication of US20050004641A1 publication Critical patent/US20050004641A1/en
Application status is Abandoned legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362Heart stimulators
    • A61N1/3621Heart stimulators for treating or preventing abnormally high heart rate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/38Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
    • A61N1/39Heart defibrillators
    • A61N1/3956Implantable devices for applying electric shocks to the heart, e.g. for cardioversion
    • A61N1/3962Implantable devices for applying electric shocks to the heart, e.g. for cardioversion in combination with another heart therapy

Abstract

An apparatus is provided for reducing the formation and migration of blood clots from an atrial appendage, such as the left atrial appendage, to the blood vessel system of a patient. The apparatus comprises an atrial pacer to treat non-rheumatic atrial fibrillation (NRAF) of an atrial appendage so that the formation blood clots within the atrial appendage is decreased or eliminated. In addition, the apparatus includes a blood clot filter supported by the atrial pacer proximate the atrial appendage and the atrium to reduce the migration of blood clots from the atrial appendage into the blood vessel system of a patient.

Description

    RELATED APPLICATIONS
  • This is a continuation application of U.S. application Ser. No. 10/163,021, filed Jun. 4, 2002, which in turn claims the benefit of priority of U.S. Provisional Application No. 60/295,683, filed on Jun. 4, 2001, the entire contents of which application(s) are incorporated herein by reference.
  • FIELD OF THE INVENTION
  • The present invention relates generally to a device that deters migration of emboli from an atrial appendage into the vascular system of a patient, and more particularly to a device that includes a filter to deter such migration and a pacer to deter the formation of emboli such as blood clots within the atrial appendage.
  • BACKGROUND OF THE INVENTION
  • Non-rheumatic atrial fibrillation (NRAF) is associated with thromboembolic complications such as strokes. For example, when a thrombus or embolus occludes a vessel supplying blood to the brain, a stroke may result causing temporary or lasting paralysis of a part of the body or, in severe cases, death. Blockage of other blood vessels can occur as well causing attendant health concerns, including heart attack or gangrene. Presently, a five percent risk of stroke per year in a largely aging population causes NRAF to be a significant health concern. Given the potentially irreversible and destructive nature of such blood vessel occlusion, safe and effective methods are needed to eliminate embolic material like blood clots from the vascular system, some of which may be formed within an atrial appendage of the heart.
  • The left atrial appendage forms a small protrusion which is attached to the lateral wall of the left atrium between the mitral valve and the root of the left pulmonary vein and normally contracts along with the left atrium. Atrial fibrillation is a cardiac condition wherein the atria beat faster than the ventricles, causing the ventricles to contract irregularly and consequently eject less blood into the vascular system. A major problem associated with atrial fibrillation is pooling of blood in the left atrial appendage.
  • During NRAF the left atrial appendage may not fully contract, leaving stagnant blood within the left atrial appendage. In turn, the stagnant blood may create a condition favorable to the formation of blood clots within the left atrial appendage. Such clots may travel from the left atrial appendage into the left atrium and into the vascular system, thereby increasing the danger of stroke or cardiac blockage.
  • Traditional treatments to mitigate the risks posed by blood clots include the use of anticoagulants to dissolve the clots. For example, recently published results from stroke prevention trials suggest that prophylaxis with anticoagulation is beneficial to patients with non-rheumatic, non-valvular atrial fibrillation. Current therapeutic interventions include anticoagulation with coumedin. In addition, therapeutic interventions include the use of atrial rate regulating medications. However, both of these treatment approaches pose potential complications such as internal bleeding, as well as other negative side effects caused by the rate regulating therapeutic agents.
  • In addition to pharmacological treatments, complex radical surgical methods are available to treat atrial fibrillation. Such treatments include, for example, atrial incisions or removal of the left atrial appendage, which have been attempted in a limited, experimental way. Such approaches are highly invasive and pose a risk of mortality to the patient. Thus, a pressing need exists for means by which the formation of blood clots the left atrial appendage is substantially deterred while preventing the migration of any blood clots which may form from entering the vascular system.
  • U.S. Pat. No. 6,152,144 to Lesh et al., for example, discloses a device and method for obliterating or occluding a body cavity or passageway. Specifically, the patent to Lesh is directed to a device and method for obliterating or occluding the left atrial appendage of a patient's heart. In one embodiment, Lesh et al. disclose a frame structure having a barrier or mesh material disposed over it to act as a barrier to the passage of embolic material.
  • However, Lesh et al. do not disclose a device or method suited to treat atrial fibrillation, or other arrhythmias of the heart, to thereby prevent the formation of clots in the left atrial appendage. As such, the barrier embodiment of Lesh et al. permits ongoing formation of clots within the left atrial appendage, which may eventually occlude the barrier material to prevent fluid flow as well as embolic material flow through the occluded barrier. Such a situation may present a health concern as the left atrial appendage contracts and the blood enclosed therein is unable to exit the left atrial appendage. Such contraction may result in an increased pressure in the left atrial appendage capable of weakening the wall of the left atrial appendage. Additionally, as the barrier embodiment of Lesh et al. does not prevent the formation of clots, it is possible that the volume of the left atrial appendage may eventually be filled with coagulated blood. Thus, filtering alone poses possible added health concerns.
  • Regarding the treatment of atrial fibrillation, it is known to use a pacemaker, for example, as disclosed in U.S. Pat. No. 6,178,351 B1 to Mower. Mower discloses a pacemaker that is capable of pacing the atria from multiple sites, but does not address prevention of migration of embolic material within the vascular system. Moreover, neither Mower nor Lesh suggests combining a pacer with an embolic barrier for use in the heart.
  • Accordingly, there is a need for an apparatus for mitigating the risks associated with emboli originating in the left atrial appendage and also for reducing the tendency of such emboli, such as blood clots, to form therein.
  • SUMMARY OF THE INVENTION
  • An apparatus is provided for deterring the formation and migration of blood clots from an atrial appendage, such as a left or right atrial appendage, into the blood vessel system, i.e. vascular system, of a patient. In particular, an apparatus of the present invention comprises an atrial pacer to treat non-rheumatic atrial fibrillation (NRAF) or other arrhythmias of an atrial appendage so that the formation of blood clots within such atrial appendage is decreased or eliminated. In addition, the apparatus provides a blood clot filter to deter the migration of blood clots from an atrial appendage into the blood vessel system of a patient.
  • More specifically, the apparatus comprises a filter for reducing the transport of emboli from an atrial appendage to an atrium of the heart. The filter is formed to provide a structure suitable for separating blood clots from the blood and for reducing passage of blood clots from the atrial appendage into the atrium and general circulation. In accordance with one aspect of the invention, the filter can take the form of a plurality of spokes extending outwardly from the atrial pacer. In another aspect, the filter can take the form of a mesh having pores sized to deter the passage of blood clots.
  • In accordance with another aspect of the invention, the apparatus comprises an atrial pacer which supports the filter between an atrial appendage and the atrium. The atrial pacer is adapted to be in contact with a wall of the atrial appendage so the atrial pacer may detect and reduce atrial fibrillation in the atrial appendage. The pacer also includes a sensor which may form an integral part of the atrial pacer for sensing fibrillation in the atrial appendage. In an alternative arrangement, the sensor may be adapted to be positioned externally to the heart. In this external arrangement, a lead wire may be provided between the sensor and the atrial wall, to provide sensing contact between the sensor and the atrial wall. The atrial pacer also comprises a stimulator for stimulating the atrial appendage. The simulator may take the form of an electrode for making electrical contact with the wall of the atrial appendage to apply stimulating signals to the atrial appendage. The stimulator may be activated in response to a signal from the sensor indicating the presence of NRAF, or other arrythmias, in the atrial appendage.
  • A control unit adapted to be positioned externally to the heart may optionally be provided for controlling the atrial pacer. The control unit may communicate with the sensor and/or the stimulator using a lead wire or wireless technology. In addition, the sensor may be disposed within the control unit. For example, in the arrangement where the sensor is positioned externally to the heart, the sensor may be incorporated within the control unit.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The foregoing summary and the following detailed description of the preferred embodiments of the present invention will be best understood when read in conjunction with the appended drawings, in which:
  • FIG. 1 is a schematic perspective view showing an exemplary device of the present invention having a mesh filter;
  • FIG. 2 is a schematic perspective view showing an exemplary device of the present invention having a filter which includes a plurality of spokes;
  • FIG. 3 is a schematic view of the exemplary device shown in FIG. 1 disposed within a left atrial appendage;
  • FIG. 4 is a schematic view of the exemplary device shown in FIG. 2 disposed within a left atrial appendage;
  • FIG. 5 is a schematic block diagram of a first exemplary configuration of an atrial pacer of the present invention having a control unit which includes a sensor and lead wire for detecting a selected condition of the heart;
  • FIG. 6 is a block diagram of a second exemplary configuration of an atrial pacer of the present invention having a control unit for communication with stimulator and sensor;
  • FIG. 7 is a block diagram of a rechargeable configuration of an atrial pacer of the present invention;
  • FIG. 8 is a schematic view of the exemplary device shown in FIG. 1 with the filter collapsed against the body of the device; and
  • FIG. 9 is a schematic view of the exemplary device shown in FIG. 2 with the spokes collapsed against the body of the device.
  • DETAILED DESCRIPTION OF THE INVENTION
  • A cardiac stimulating apparatus 10, 100 is provided for substantially reducing the formation of blood clots in an atrial appendage of a heart, such as the left atrial appendage 210, and reducing the migration of such clots into the blood vessel system of a patient. The apparatus 10, 100 comprises a filtration device 28, 124 to reduce migration of embolic material, such as blood clots or the like. In addition, the apparatus 10, 100 includes an atrial pacer 12, 112 to treat arrythmias, such as non-rheumatic atrial fibrillation (NRAF), of the left atrial appendage 210 to deter the formation blood clots within the left atrial appendage 210. FIGS. 1-4 depict the general structure of a cardiac stimulating apparatus of the present invention, illustrating the cooperation between the atrial pacer 12, 112 and the filtration device, such as filter 28 or spokes 124.
  • Turning now to FIGS. 1 and 3, an embodiment of the present invention is shown in which a cardiac stimulating apparatus 10 comprises an atrial pacer 12 having an elongated generally tubular body 14 having first and second opposing ends 18, 30. The first end 18 of the atrial pacer 12 is adapted to contact the wall of the left atrial appendage 210 to support the cardiac stimulating apparatus 10 within the left atrial appendage 210. The first end 18 may include a sensing device 22 optionally disposed therein to detect NRAF or other arrhythmias in the left atrial appendage 210. In such a configuration, the sensing device 22 is adapted to be in sensing contact with the wall of the left atrial appendage 210. The first end 18 of the atrial pacer 12 also includes a stimulating device 23 for stimulating the left atrial appendage 210 in response to detection of NRAF by a detector, such as sensing device 22. The stimulating device 23 includes an electrode adapted to be in electrical contact with the wall of the atrial appendage 210 for applying stimulating signals to the atrial appendage 210. By application of an appropriate stimulating signal, NRAF can be reduced or eliminated thereby reducing the tendency of blood within the left atrial appendage 210 to form blood clots. The sensing device 22 and stimulating device 23 may comprise components known for use in atrial pacers.
  • Extending outwardly from the elongated generally tubular body 14, a filtration device is provided to deter the migration of blood clots from the left atrial appendage 210 into the left atrium 200 of the heart. As shown in FIG. 1, an embodiment of the filtration device may take the form of a mesh-like or sieve-like filter 28. The filter 28 may have a generally conical shape as shown, for example, with the narrower end of the conical filter 28 attached to the atrial pacer 12 proximate to the first end 18 of the atrial pacer 12. Alternatively, the filter 28 may be attached to the atrial pacer 12 at any point along the elongated body 14. The filter 28 may have any shape suited to substantially fill the opening defined by the intersection of the left atrial appendage 210 and the left atrium 200, such as a portion of a sphere, flat sheet, or other shape.
  • The mesh-like material of the filter 28 may be formed from a metal, such as a stainless-steel, for example. Alternatively, the filter 28 may be formed from a polymeric material, such as a Nylon or Dacron mesh. Other suitable materials such as PTFE or polyamides may also be used. In particular, it is preferable that the filter 28 be formed of a resilient material capable of being collapsed about the body 14 of the atrial pacer 12, as shown in FIG. 8, to facilitate introduction of the cardiac stimulating device 10 into a patient, for example, via a catheter. The resilient material is chosen such that upon removal of the cardiac stimulating device 10 from the catheter, the filter 28 expands to a desired shape and size to permit the opening of the left atrial appendage 210 to be substantially sealed. Regardless of the material from which the filter 28 is formed, the filter 28 is formed to provide pores having a transverse dimensions of about 1 mm or other size sufficiently small to prevent the passage of blood clots or other thromboembolic material of like or greater size. In particular, it may be desirable for the pore size to have a transverse dimension up to about 0.1 mm.
  • The wider end of the filter 28 includes a rim portion 20 which defines the base of the filter 28. The rim portion 20 is sized to circumscribe the opening between the left atrial appendage 210 and left atrium 200, so that emplacement the cardiac stimulating device 10 in the left atrial appendage 210 generally positions the rim portion 20 near the opening left atrial appendage 210 so as to form and maintain a seal therewith. To effect and maintain such a seal, the rim portion 20 may be formed of or covered by a soft polymer material. The rim portion 20 may have a transverse dimension of about 2 to 40 mm, preferably about 25 to 35 mm. The transverse dimension of the rim portion 20 should be selected with regard to the size of the left atrial appendage opening, which may vary among patients, especially those patients having heart disease related conditions.
  • The rim portion 20 may also include a plurality of holes through which sutures may be placed to anchor the rim portion 20 proximate to the opening of the left atrial appendage 210. Alternatively or additionally, the rim portion 20 may have a spring-like action which causes the rim portion 20 to expand generally radially outward from the longitudinal axis of the atrial pacer 12, so that the rim portion 20 applies pressure against a region proximate the opening of the left atrial appendage 210 to form a seal proximate the opening of the left atrial appendage 210. For example, the rim portion 20 may be formed of a shape memory metal, such as NiTi, having a memorized shape larger than that of the opening of the left atrial appendage 210 to supply the radially outward pressure on the opening. The filter 28 is attached to the atrial pacer 12 at such a location so as to permit the rim portion 20 to substantially form a seal within the left atrial appendage opening and to permit the first end 18 of the atrial pacer 12 to contact the wall of the atrial appendage 210.
  • Referring now to FIGS. 2 and 4, an alternative embodiment of the cardiac stimulating apparatus 100 is shown where the filtration device comprises a plurality of spokes 124 extending generally radially outwardly from the atrial pacer 112, to deter the migration of blood clots from the left atrial appendage 210 of the heart to the left atrium 200 of the heart. The atrial pacer 112 of the alternative embodiment comprises an elongated generally tubular body 114 having first and second ends 118, 130, a stimulating device 123, and an optional sensing device 122 similar to like components 23 and 22 described above with regard to the previous embodiment.
  • The spokes 124 each comprise a first end 125 attached to the elongated body 114 of the atrial pacer 112 and a second end 127 of the spokes 124 for engaging a region of the heart in the vicinity of the left atrial appendage 210. The second end 127 of the spokes 124 may terminate in a hook-like tine 126 formed to anchor the spokes 124 and retain the atrial pacer 112 within the left atrial appendage 210. In addition, all or some of the second ends 127 of the spokes 124 may include a hole suitable for placing a suture therethrough for attachment to the left atrial appendage 210. The number of spokes 124 employed should be sufficiently numerous to create interstices between the spokes 124 sufficiently small to deter the passage of embolic material through the interstices.
  • The first ends 125 of the plurality a spokes 124 may be attached to the body 114 of the atrial pacer 112 at a common distance from the first end 118 of the atrial pacer 112. Alternatively, the first ends 125 of the plurality of spokes 124 may be attached to the body 114 of the atrial pacer 112 at varying distances from the first end 118 of the atrial pacer 112. Providing spokes 124 at a variety of distances from the first end 118 of the atrial pacer 112 may be useful to create a tortuous path to deter the flow of embolic material. For example, a first set of spokes 124 may have first ends 125 adjoining the atrial pacer 112 at a common distance from the first end 118 around the circumference of the atrial pacer 112. A second set of spokes may have first ends adjoining the atrial pacer 112 at a further distance from the first end 118 of the atrial pacer 112 than the first set of spokes 124. In addition, the second set of spokes may be oriented circumferentially to overlap with the interstices formed among the first set of spokes 124, as viewed from the first end 118 of the atrial pacer 112. Likewise, additional set of spokes 124 may be included to effect additional blockage of embolic material flow. Moreover, some or all of the spokes 124 may extend outwardly from the atrial pacer 112 along non-radial directions, to enhance blockage of embolic material.
  • The spokes 124 may be formed of any suitable material such as a metal or polymeric material like those described above with regard to the mesh-like filter 28. It is also desirable that the spokes 124 be sufficiently pliable to permit the spokes 124 to be disposed along the body 114 of the atrial pacer 112, as shown in FIG. 9, while the cardiac stimulating device 100 is placed into a patient via a catheter.
  • In addition, it is desirable that the spokes 124 be sufficiently resilient so that they expand away from the body 114 of the atrial pacer 112 once removed from the catheter, permitting the spokes 124 to engage the wall of left atrial appendage 210. In addition, the spokes 124 are formed sufficiently long and disposed at an angle away from the body 114 of the atrial pacer 112 to cause the second ends 127 of the spokes 124 to be biased against the wall of the left atrial appendage 210 to retain the cardiac stimulating device 100 in position. For example, the spokes 125 may have a length to allow the second ends 127 of the spokes 124 to terminate proximate the left atrial appendage opening. The spokes 124 are attached to the atrial pacer 112 at such a location as to permit the spokes 124 to partially occlude the opening of the left atrial appendage and to permit the first end 118 of the atrial pacer 112 to contact the wall of the atrial appendage 210.
  • In each of the above embodiments, the atrial pacer 12, 112 may include a power source 16, 116, such as a rechargeable battery, within the generally elongated body 14, 114 along with appropriate circuitry known for the operation of atrial sensing and stimulating devices. Alternatively or additionally, the cardiac stimulating device 10, 100 may include a lead wire 32, 132 to provide power and/or a control signal to the atrial pacer 12, 112 from a remote device. A control unit for use external to the left atrial appendage 210, or external to a patient's body, may be provided for housing circuitry of the atrial pacer 12, 112. Providing such a control unit may also be desirable, since inclusion of control circuitry therein may permit the atrial pacer 12, 112 to have a smaller overall the size.
  • Referring to FIGS. 5-7, three exemplary embodiments are shown of device arrangements which include remote control and/or power supply units. In particular, with regard to FIG. 5, a control unit 302 is shown for controlling and powering the stimulator 308 of an atrial pacer. The stimulator 308 may correspond to the stimulating devices 23, 123 depicted in FIGS. 1 and 2 as described above. In the configuration of FIG. 5, a sensor 304 is incorporated in a remotely located control unit 302 rather than in the elongated body 14, 114 of the atrial pacer 12, 112. The sensor 304 is in sensing contact with the left atrial appendage 210 via lead wire 306 to detect NRAF in the atrial appendage 210. Hence, for this configuration the sensing device 22, 122 described above as being disposed within the first end 18, 118 of the atrial pacer 12,112 is not required to be disposed therein.
  • The control unit 302 further includes control circuitry 310 for processing the signal detected by the sensor 304 and controlling the stimulator 308 in response to the detected signal. For example, when the control circuitry 310 receives a signal from the sensor 304 indicative of NRAF of the left atrial appendage 210, the control circuitry delivers a control signal to the stimulator 308 to cause the stimulator 308 to stimulate the left atrial appendage 210 to alleviate the NRAF. Hence, by correcting NRAF, formation of blood clots in the left atrial appendage 210 is reduced by limiting the presence of stagnant blood in the left atrial appendage 210. The control unit 302 communicates with the stimulator 308 via an optional lead wire 309 or via wireless communication.
  • Wireless communication can be effected via optional antennas 314, 315 connected to the control unit 302 and the stimulator 308, respectively. The antenna 315 of the stimulator 308 may be disposed, for example, at the second end 30, 130 of the atrial pacer 12, 112. The control unit 302 may include a power source 312 to power the control unit 302 and to optionally power the stimulator 308 via lead wire 307.
  • Referring to FIG. 6, a further embodiment of the present invention is shown which is substantially similar to that shown in FIG. 5. The embodiment of FIG. 6 differs from FIG. 5 in that the control unit 402 of FIG. 6 does not include a sensor. Instead, a sensor 404 is provided in the elongated body 14, 114 of the atrial pacer 12, 112 along with a stimulator 408. Such a sensor 404 may correspond to the sensing devices 22, 122 shown in FIGS. 1 and 2 and described above. Since the sensor 404 and stimulator 408 are both disposed within the body 14, 114 of the atrial pacer 12, 112, the sensor 404 and stimulator 408 may communicate directly with each other so that the stimulator 408 may stimulate left atrial appendage 210 in response to the detection of NRAF by the sensor 404. Alternatively, to minimize the size of the atrial pacer, control circuitry may be provided in a remote control unit 402 to receive data from the sensor 404, to process such data, and control the stimulator 408 in response to such data. Communication between the control unit 402 and the stimulator 408 and sensor 404 may be effected via an optional lead wire 409 or via wireless communication using optional antennas 414, 415, in a similar manner to that described above with regard to the embodiment of FIG. 5.
  • In addition, as shown in FIG. 7, the atrial pacer 512 may be configured to be recharged by a remote charger 506. In such an embodiment, the atrial pacer 512 includes a first electrical coil 502 electrically coupled to an energizer unit 516, such as a battery, of the atrial pacer 512. The recharger 506 has a corresponding second electrical coil 504 which may be electromagnetically coupled to the first coil 502 to transmit electromagnetic energy thereto from the charger 506, through the patient's skin 508, and thence into the energizer unit 516 of the atrial pacer 512.
  • After insertion of the cardiac stimulating device 10, 100 into the heart so that the filtration device 28, 126 expands and sensing device 22, 122 or sensor 304, 404 is placed in sensing contact with the left atrial appendage 210, the cardiac stimulating device 10, 100 monitors for the presence of NRAF. Upon detection of NRAF, the stimulator 23, 123 applies a correcting stimulating electrical signal to the left atrial appendage 210 in response to the detected NRAF condition. By such treatment of the left atrial appendage 210 to minimize NRAF, the formation of blood clots attributable to NRAF is minimized. In addition, the presence of the filtration device 28, 126 provides continuous filtration of the blood exiting the left atrial appendage 210, so as to prevent the egress of emboli therefrom.
  • These and other advantages of the present invention will be apparent to those skilled in the art. Accordingly, it will be recognized by those skilled in the art that changes or modifications may be made to the above-described embodiments without departing from the broad inventive concepts of the invention. For example, the atrial pacer could be replaced and/or adapted to function as a ventricular defibrillator to treat ventricular tachycardia. Likewise, the atrial pacer could be replaced by a device that functions as a combined atrial pacer and ventricular defibrillator. It should therefore be understood that this invention is not limited to the particular embodiments described herein, but is intended to include all changes and modifications that are within the scope and spirit of the invention as set forth in the claims.

Claims (26)

1. A cardiac stimulating apparatus comprising:
a stimulator comprising an end for making at least one of sensing and stimulating contact with a wall of a heart, said stimulator comprising at least one of a sensor and a stimulator; and
a filtration device mounted to said stimulator distal the end thereof and adapted for deterring movement of emboli through the filtration device.
2. The cardiac stimulating apparatus according to claim 1 wherein the filtration device comprises a plurality of spokes.
3. The cardiac stimulating apparatus according to claim 2 wherein the spokes include tines to attach the filtration device to the heart.
4. The cardiac stimulating apparatus according to claim 1 wherein the spokes extend generally radially outwardly from the stimulator.
5. The cardiac stimulating apparatus according to claim 1 wherein the filtration device comprises a mesh.
6. The cardiac stimulating apparatus according to claim 1 wherein the filtration device includes at least one of an expandable mesh and a plurality of expandable spokes.
7. The cardiac stimulating apparatus according to claim 6 wherein said one of said expandable mesh and said plurality of expandable spokes are collapsible to be disposed near the stimulator for implantation into the heart through a catheter.
8. The cardiac stimulating apparatus according to claim 1 wherein stimulator includes a control unit adapted to be disposed external to the heart.
9. The cardiac stimulating apparatus according to claim 8 wherein the control unit is adapted to be in wireless communication with the sensor.
10. The cardiac stimulating apparatus according to claim 8 wherein the control unit is adapted to be in wireless communication with the stimulator.
11. The cardiac stimulating apparatus according to claim 1 wherein the stimulator is adapted to apply a stimulating signal to the heart wall and the sensor is adapted to be in sensing contact with the heart wall.
12. The cardiac stimulating apparatus according to claim 1 comprising:
i) a charger adapted to be disposed external to a patient's body for providing a power signal in the form of electromagnetic energy; and
ii) an energizer adapted to be disposed internal to a patient's body for receiving the power signal provided by the generator unit to energize said stimulator.
13. The cardiac stimulating apparatus according to claim 12 wherein the generator unit comprises a first coil for transmitting the power signal and the energizing unit comprises a second coil for receiving the power signal.
14. A cardiac stimulating apparatus comprising:
a stimulator comprising an elongated body adapted at one end thereof for making at least one of sensing and stimulating contact with a wall of an atrial appendage of a heart, said stimulator comprising an atrial sensor and an atrial stimulator disposed in said elongated body; and
a filtration device mounted to said elongated body distal the one end thereof and adapted for deterring movement of emboli between the atrial appendage and an atrium of the heart.
15. The cardiac stimulating apparatus according to claim 14 wherein the filtration device comprises a plurality of spokes.
16. The cardiac stimulating apparatus according to claim 15 wherein the spokes include tines to attach the filtration device to the atrial appendage.
17. The cardiac stimulating apparatus according to claim 14 wherein the spokes extend generally radially outwardly from the stimulator.
18. The cardiac stimulating apparatus according to claim 14 wherein the filtration device comprises a mesh.
19. The cardiac stimulating apparatus according to claim 14 wherein the filtration device includes at least one of an expandable mesh and a plurality of expandable spokes.
20. The cardiac stimulating apparatus according to claim 19 wherein said one of said expandable mesh and said plurality of expandable spokes are collapsible to be disposed near the stimulator for implantation into the atrial appendage through a catheter.
21. The cardiac stimulating apparatus according to claim 14 wherein the stimulator includes a control unit adapted to be disposed external to the heart.
22. The cardiac stimulating apparatus according to claim 21 wherein the control unit is adapted to be in wireless communication with the sensor.
23. The cardiac stimulating apparatus according to claim 21 wherein the control unit is adapted to be in wireless communication with the stimulator.
24. The cardiac stimulating apparatus according to claim 14 wherein the stimulator is adapted to apply a stimulating signal to the wall of the atrial appendage and the sensor is adapted to be in sensing contact with a wall of the atrial appendage.
25. The cardiac stimulating apparatus according to claim 14 comprising:
i) a charger adapted to be disposed external to a patient's body for providing a power signal in the form of electromagnetic energy; and
ii) an energizer adapted to be disposed internal to a patient's body for receiving the power signal provided by the generator unit to energize said stimulator.
26. The cardiac stimulating apparatus according to claim 25 wherein the generator unit comprises a first coil for transmitting the power signal and the energizing unit comprises a second coil for receiving the power signal.
US10/897,504 2001-06-04 2004-07-23 Cardiac stimulating apparatus having a blood clot filter and atrial pacer Abandoned US20050004641A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US29568301P true 2001-06-04 2001-06-04
US10/163,021 US6941169B2 (en) 2001-06-04 2002-06-04 Cardiac stimulating apparatus having a blood clot filter and atrial pacer
US10/897,504 US20050004641A1 (en) 2001-06-04 2004-07-23 Cardiac stimulating apparatus having a blood clot filter and atrial pacer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/897,504 US20050004641A1 (en) 2001-06-04 2004-07-23 Cardiac stimulating apparatus having a blood clot filter and atrial pacer

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/163,021 Continuation US6941169B2 (en) 2001-06-04 2002-06-04 Cardiac stimulating apparatus having a blood clot filter and atrial pacer

Publications (1)

Publication Number Publication Date
US20050004641A1 true US20050004641A1 (en) 2005-01-06

Family

ID=23138789

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/163,021 Active 2023-02-07 US6941169B2 (en) 2001-06-04 2002-06-04 Cardiac stimulating apparatus having a blood clot filter and atrial pacer
US10/897,504 Abandoned US20050004641A1 (en) 2001-06-04 2004-07-23 Cardiac stimulating apparatus having a blood clot filter and atrial pacer

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10/163,021 Active 2023-02-07 US6941169B2 (en) 2001-06-04 2002-06-04 Cardiac stimulating apparatus having a blood clot filter and atrial pacer

Country Status (5)

Country Link
US (2) US6941169B2 (en)
EP (1) EP1392394A4 (en)
JP (1) JP2005508208A (en)
CA (1) CA2449468A1 (en)
WO (1) WO2002098282A2 (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090005777A1 (en) * 2001-04-24 2009-01-01 Vascular Closure Systems, Inc. Arteriotomy closure devices and techniques
US20090143808A1 (en) * 2001-04-24 2009-06-04 Houser Russell A Guided Tissue Cutting Device, Method of Use and Kits Therefor
US20090143789A1 (en) * 2007-12-03 2009-06-04 Houser Russell A Vascular closure devices, systems, and methods of use
WO2012109297A3 (en) * 2011-02-10 2012-11-01 Atrial Innovations, Inc. Atrial appendage occlusion and arrhythmia treatment
US8992567B1 (en) 2001-04-24 2015-03-31 Cardiovascular Technologies Inc. Compressible, deformable, or deflectable tissue closure devices and method of manufacture
US9295393B2 (en) 2012-11-09 2016-03-29 Elwha Llc Embolism deflector
US9345460B2 (en) 2001-04-24 2016-05-24 Cardiovascular Technologies, Inc. Tissue closure devices, device and systems for delivery, kits and methods therefor
US9526522B2 (en) 2013-09-27 2016-12-27 Medtronic, Inc. Interventional medical systems, tools, and assemblies
US9675798B2 (en) 2014-08-26 2017-06-13 Medtronic, Inc. Interventional medical systems, devices, and components thereof
US10143823B2 (en) 2016-04-29 2018-12-04 Medtronic, Inc. Interventional medical systems and improved assemblies thereof and associated methods of use
US10300286B2 (en) 2013-09-27 2019-05-28 Medtronic, Inc. Tools and assemblies thereof for implantable medical devices

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6714967B1 (en) 1999-07-30 2004-03-30 Microsoft Corporation Integration of a computer-based message priority system with mobile electronic devices
US20060052821A1 (en) 2001-09-06 2006-03-09 Ovalis, Inc. Systems and methods for treating septal defects
US6776784B2 (en) 2001-09-06 2004-08-17 Core Medical, Inc. Clip apparatus for closing septal defects and methods of use
US8579936B2 (en) 2005-07-05 2013-11-12 ProMed, Inc. Centering of delivery devices with respect to a septal defect
US6702835B2 (en) 2001-09-07 2004-03-09 Core Medical, Inc. Needle apparatus for closing septal defects and methods for using such apparatus
EP1467661A4 (en) 2001-12-19 2008-11-05 Nmt Medical Inc Septal occluder and associated methods
US7318833B2 (en) 2001-12-19 2008-01-15 Nmt Medical, Inc. PFO closure device with flexible thrombogenic joint and improved dislodgement resistance
AU2003220502A1 (en) 2002-03-25 2003-10-13 Nmt Medical, Inc. Patent foramen ovale (pfo) closure clips
CA2488337A1 (en) 2002-06-05 2003-12-18 Nmt Medical, Inc. Patent foramen ovale (pfo) closure device with radial and circumferential support
US20040147973A1 (en) * 2002-06-27 2004-07-29 Hauser Robert G. Intra cardiac pacer and method
US7766820B2 (en) 2002-10-25 2010-08-03 Nmt Medical, Inc. Expandable sheath tubing
AU2003294682A1 (en) 2002-12-09 2004-06-30 Nmt Medical, Inc. Septal closure devices
US7658747B2 (en) 2003-03-12 2010-02-09 Nmt Medical, Inc. Medical device for manipulation of a medical implant
US8239045B2 (en) 2003-06-04 2012-08-07 Synecor Llc Device and method for retaining a medical device within a vessel
EP1633434B1 (en) 2003-06-04 2014-11-19 Synecor Intravascular electrophysiological system
US7082336B2 (en) * 2003-06-04 2006-07-25 Synecor, Llc Implantable intravascular device for defibrillation and/or pacing
US7617007B2 (en) 2003-06-04 2009-11-10 Synecor Llc Method and apparatus for retaining medical implants within body vessels
US9861346B2 (en) 2003-07-14 2018-01-09 W. L. Gore & Associates, Inc. Patent foramen ovale (PFO) closure device with linearly elongating petals
US8480706B2 (en) 2003-07-14 2013-07-09 W.L. Gore & Associates, Inc. Tubular patent foramen ovale (PFO) closure device with catch system
ES2428967T3 (en) 2003-07-14 2013-11-12 W.L. Gore & Associates, Inc. tubular closure device patent foramen ovale (PFO) retention system
CA2536368A1 (en) 2003-08-19 2005-03-03 Nmt Medical, Inc. Expandable sheath tubing
EP1670360B1 (en) * 2003-09-12 2007-10-17 NMT Medical, Inc. Device for preventing formation of thrombi in the left atrial appendage
US20050273119A1 (en) 2003-12-09 2005-12-08 Nmt Medical, Inc. Double spiral patent foramen ovale closure clamp
US7747335B2 (en) 2003-12-12 2010-06-29 Synecor Llc Implantable medical device having pre-implant exoskeleton
US20110208233A1 (en) * 2004-01-22 2011-08-25 Mcguckin Jr James F Device for preventing clot migration from left atrial appendage
US20050192626A1 (en) 2004-01-30 2005-09-01 Nmt Medical, Inc. Devices, systems, and methods for closure of cardiac openings
US7871419B2 (en) 2004-03-03 2011-01-18 Nmt Medical, Inc. Delivery/recovery system for septal occluder
US20050234540A1 (en) * 2004-03-12 2005-10-20 Nmt Medical, Inc. Dilatation systems and methods for left atrial appendage
US20050234543A1 (en) * 2004-03-30 2005-10-20 Nmt Medical, Inc. Plug for use in left atrial appendage
US7806846B2 (en) * 2004-03-30 2010-10-05 Nmt Medical, Inc. Restoration of flow in LAA via tubular conduit
ES2529352T3 (en) 2004-04-08 2015-02-19 Aga Medical Corporation Occluders flange
US20050267524A1 (en) 2004-04-09 2005-12-01 Nmt Medical, Inc. Split ends closure device
US8361110B2 (en) 2004-04-26 2013-01-29 W.L. Gore & Associates, Inc. Heart-shaped PFO closure device
US8308760B2 (en) 2004-05-06 2012-11-13 W.L. Gore & Associates, Inc. Delivery systems and methods for PFO closure device with two anchors
US7842053B2 (en) 2004-05-06 2010-11-30 Nmt Medical, Inc. Double coil occluder
CA2563298A1 (en) 2004-05-07 2005-11-24 Nmt Medical, Inc. Catching mechanisms for tubular septal occluder
US7704268B2 (en) 2004-05-07 2010-04-27 Nmt Medical, Inc. Closure device with hinges
CA2581677C (en) 2004-09-24 2014-07-29 Nmt Medical, Inc. Occluder device double securement system for delivery/recovery of such occluder device
US8277480B2 (en) 2005-03-18 2012-10-02 W.L. Gore & Associates, Inc. Catch member for PFO occluder
US7962208B2 (en) * 2005-04-25 2011-06-14 Cardiac Pacemakers, Inc. Method and apparatus for pacing during revascularization
US8025668B2 (en) * 2005-04-28 2011-09-27 C. R. Bard, Inc. Medical device removal system
US8391990B2 (en) 2005-05-18 2013-03-05 Cardiac Pacemakers, Inc. Modular antitachyarrhythmia therapy system
US20070005097A1 (en) * 2005-06-20 2007-01-04 Renati Richard J Intravascular filter
US7846179B2 (en) 2005-09-01 2010-12-07 Ovalis, Inc. Suture-based systems and methods for treating septal defects
EP1962695A1 (en) 2005-12-22 2008-09-03 NMT Medical, Inc. Catch members for occluder devices
US7627376B2 (en) * 2006-01-30 2009-12-01 Medtronic, Inc. Intravascular medical device
US7616992B2 (en) * 2006-01-30 2009-11-10 Medtronic, Inc. Intravascular medical device
US7519424B2 (en) * 2006-01-30 2009-04-14 Medtronic, Inc. Intravascular medical device
US8870913B2 (en) 2006-03-31 2014-10-28 W.L. Gore & Associates, Inc. Catch system with locking cap for patent foramen ovale (PFO) occluder
CA2647505C (en) 2006-03-31 2014-07-29 Nmt Medical, Inc. Deformable flap catch mechanism for occluder device
US8551135B2 (en) 2006-03-31 2013-10-08 W.L. Gore & Associates, Inc. Screw catch mechanism for PFO occluder and method of use
WO2008124603A1 (en) 2007-04-05 2008-10-16 Nmt Medical, Inc. Septal closure device with centering mechanism
WO2008131167A1 (en) 2007-04-18 2008-10-30 Nmt Medical, Inc. Flexible catheter system
CA2687777A1 (en) * 2007-05-31 2008-12-18 Rex Medical, L.P. Fallopian tube occlusion device
EP2150181A1 (en) * 2007-05-31 2010-02-10 Rex Medical, L.P. Closure device for left atrial appendage
US20130165967A1 (en) 2008-03-07 2013-06-27 W.L. Gore & Associates, Inc. Heart occlusion devices
US8541131B2 (en) * 2009-05-29 2013-09-24 Medtronic, Inc. Elongate battery for implantable medical device
US20100305627A1 (en) * 2009-05-29 2010-12-02 Medtronic, Inc. Battery with suture hole
US9099720B2 (en) 2009-05-29 2015-08-04 Medtronic, Inc. Elongate battery for implantable medical device
US20100304209A1 (en) * 2009-05-29 2010-12-02 Medtronic, Inc. Elongate battery for implantable medical device
US20110082495A1 (en) * 2009-10-02 2011-04-07 Ruiz Carlos E Apparatus And Methods For Excluding The Left Atrial Appendage
US20110224495A1 (en) * 2010-03-12 2011-09-15 Tyco Healthcare Group Lp Surgical access port
WO2013009872A1 (en) 2011-07-11 2013-01-17 The Regents Of The University Of Michigan Multimodality left atrial appendage occlusion device
US9770232B2 (en) 2011-08-12 2017-09-26 W. L. Gore & Associates, Inc. Heart occlusion devices
WO2015106015A1 (en) 2014-01-10 2015-07-16 Cardiac Pacemakers, Inc. Systems and methods for detecting cardiac arrhythmias
US9808230B2 (en) 2014-06-06 2017-11-07 W. L. Gore & Associates, Inc. Sealing device and delivery system
WO2016033197A2 (en) 2014-08-28 2016-03-03 Cardiac Pacemakers, Inc. Medical device with triggered blanking period
WO2016126968A1 (en) 2015-02-06 2016-08-11 Cardiac Pacemakers, Inc. Systems and methods for safe delivery of electrical stimulation therapy
EP3253450A1 (en) 2015-02-06 2017-12-13 Cardiac Pacemakers, Inc. Systems and methods for treating cardiac arrhythmias
WO2016130477A2 (en) 2015-02-09 2016-08-18 Cardiac Pacemakers, Inc. Implantable medical device with radiopaque id tag
CN107427222A (en) 2015-03-18 2017-12-01 心脏起搏器股份公司 Communications in a medical device system with link quality assessment
US10050700B2 (en) 2015-03-18 2018-08-14 Cardiac Pacemakers, Inc. Communications in a medical device system with temporal optimization
US9526891B2 (en) 2015-04-24 2016-12-27 Medtronic, Inc. Intracardiac medical device
EP3337558A1 (en) 2015-08-20 2018-06-27 Cardiac Pacemakers, Inc. Systems and methods for communication between medical devices
US9968787B2 (en) 2015-08-27 2018-05-15 Cardiac Pacemakers, Inc. Spatial configuration of a motion sensor in an implantable medical device
US9956414B2 (en) 2015-08-27 2018-05-01 Cardiac Pacemakers, Inc. Temporal configuration of a motion sensor in an implantable medical device
WO2017040115A1 (en) 2015-08-28 2017-03-09 Cardiac Pacemakers, Inc. System for detecting tamponade
US10226631B2 (en) 2015-08-28 2019-03-12 Cardiac Pacemakers, Inc. Systems and methods for infarct detection
CN108136189A (en) 2015-08-28 2018-06-08 心脏起搏器股份公司 Systems and methods for behaviorally responsive signal detection and therapy delivery
US10092760B2 (en) 2015-09-11 2018-10-09 Cardiac Pacemakers, Inc. Arrhythmia detection and confirmation
US10065041B2 (en) 2015-10-08 2018-09-04 Cardiac Pacemakers, Inc. Devices and methods for adjusting pacing rates in an implantable medical device
WO2017106693A1 (en) 2015-12-17 2017-06-22 Cardiac Pacemakers, Inc. Conducted communication in a medical device system
US10029107B1 (en) 2017-01-26 2018-07-24 Cardiac Pacemakers, Inc. Leadless device with overmolded components

Citations (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US178283A (en) * 1876-06-06 Improvement in vaginal syringes
US1967318A (en) * 1931-10-02 1934-07-24 Monahan William Apparatus for the treatment of the urethra
US3874388A (en) * 1973-02-12 1975-04-01 Ochsner Med Found Alton Shunt defect closure system
US3946731A (en) * 1971-01-20 1976-03-30 Lichtenstein Eric Stefan Apparatus for extracorporeal treatment of blood
US4007743A (en) * 1975-10-20 1977-02-15 American Hospital Supply Corporation Opening mechanism for umbrella-like intravascular shunt defect closure device
US4341218A (en) * 1978-05-30 1982-07-27 University Of California Detachable balloon catheter
US4585000A (en) * 1983-09-28 1986-04-29 Cordis Corporation Expandable device for treating intravascular stenosis
US4665906A (en) * 1983-10-14 1987-05-19 Raychem Corporation Medical devices incorporating sim alloy elements
US4817600A (en) * 1987-05-22 1989-04-04 Medi-Tech, Inc. Implantable filter
US4832055A (en) * 1988-07-08 1989-05-23 Palestrant Aubrey M Mechanically locking blood clot filter
US4917089A (en) * 1988-08-29 1990-04-17 Sideris Eleftherios B Buttoned device for the transvenous occlusion of intracardiac defects
US4921484A (en) * 1988-07-25 1990-05-01 Cordis Corporation Mesh balloon catheter device
US4934383A (en) * 1982-04-23 1990-06-19 George Glumac Electrode
US5078736A (en) * 1990-05-04 1992-01-07 Interventional Thermodynamics, Inc. Method and apparatus for maintaining patency in the body passages
US5108420A (en) * 1991-02-01 1992-04-28 Temple University Aperture occlusion device
US5176692A (en) * 1991-12-09 1993-01-05 Wilk Peter J Method and surgical instrument for repairing hernia
US5192301A (en) * 1989-01-17 1993-03-09 Nippon Zeon Co., Ltd. Closing plug of a defect for medical use and a closing plug device utilizing it
US5279546A (en) * 1990-06-27 1994-01-18 Lake Region Manufacturing Company, Inc. Thrombolysis catheter system
US5284488A (en) * 1992-12-23 1994-02-08 Sideris Eleftherios B Adjustable devices for the occlusion of cardiac defects
US5306234A (en) * 1993-03-23 1994-04-26 Johnson W Dudley Method for closing an atrial appendage
US5314451A (en) * 1993-01-15 1994-05-24 Medtronic, Inc. Replaceable battery for implantable medical device
US5329942A (en) * 1990-08-14 1994-07-19 Cook, Incorporated Method for filtering blood in a blood vessel of a patient
US5380299A (en) * 1993-08-30 1995-01-10 Med Institute, Inc. Thrombolytic treated intravascular medical device
US5411535A (en) * 1992-03-03 1995-05-02 Terumo Kabushiki Kaisha Cardiac pacemaker using wireless transmission
US5417699A (en) * 1992-12-10 1995-05-23 Perclose Incorporated Device and method for the percutaneous suturing of a vascular puncture site
US5421832A (en) * 1989-12-13 1995-06-06 Lefebvre; Jean-Marie Filter-catheter and method of manufacturing same
US5425744A (en) * 1991-11-05 1995-06-20 C. R. Bard, Inc. Occluder for repair of cardiac and vascular defects
US5490856A (en) * 1993-12-14 1996-02-13 Untied States Surgical Corporation Purse string stapler
US5522836A (en) * 1994-06-27 1996-06-04 Target Therapeutics, Inc. Electrolytically severable coil assembly with movable detachment point
US5527322A (en) * 1993-11-08 1996-06-18 Perclose, Inc. Device and method for suturing of internal puncture sites
US5527338A (en) * 1992-09-02 1996-06-18 Board Of Regents, The University Of Texas System Intravascular device
US5591196A (en) * 1994-02-10 1997-01-07 Endovascular Systems, Inc. Method for deployment of radially expandable stents
US5601595A (en) * 1994-10-25 1997-02-11 Scimed Life Systems, Inc. Remobable thrombus filter
US5607579A (en) * 1993-04-27 1997-03-04 Haemonetics Corporation Apheresis apparatus for separating an intermediate density component from whole blood
US5614204A (en) * 1995-01-23 1997-03-25 The Regents Of The University Of California Angiographic vascular occlusion agents and a method for hemostatic occlusion
US5626605A (en) * 1991-12-30 1997-05-06 Scimed Life Systems, Inc. Thrombosis filter
US5634936A (en) * 1995-02-06 1997-06-03 Scimed Life Systems, Inc. Device for closing a septal defect
US5634942A (en) * 1994-04-21 1997-06-03 B. Braun Celsa Assembly comprising a blood filter for temporary or definitive use and a device for implanting it
US5637097A (en) * 1992-04-15 1997-06-10 Yoon; Inbae Penetrating instrument having an expandable anchoring portion
US5709707A (en) * 1995-10-30 1998-01-20 Children's Medical Center Corporation Self-centering umbrella-type septal closure device
US5709224A (en) * 1995-06-07 1998-01-20 Radiotherapeutics Corporation Method and device for permanent vessel occlusion
US5713849A (en) * 1994-07-19 1998-02-03 Cordis Corporation Suction catheter and method
US5725568A (en) * 1995-06-27 1998-03-10 Scimed Life Systems, Inc. Method and device for recanalizing and grafting arteries
US5725552A (en) * 1994-07-08 1998-03-10 Aga Medical Corporation Percutaneous catheter directed intravascular occlusion devices
US5733294A (en) * 1996-02-28 1998-03-31 B. Braun Medical, Inc. Self expanding cardiovascular occlusion device, method of using and method of making the same
US5735290A (en) * 1993-02-22 1998-04-07 Heartport, Inc. Methods and systems for performing thoracoscopic coronary bypass and other procedures
US5749883A (en) * 1995-08-30 1998-05-12 Halpern; David Marcos Medical instrument
US5749894A (en) * 1996-01-18 1998-05-12 Target Therapeutics, Inc. Aneurysm closure method
US5766219A (en) * 1995-04-20 1998-06-16 Musc Foundation For Research Development Anatomically shaped vasoocclusive device and method for deploying same
US5769816A (en) * 1995-11-07 1998-06-23 Embol-X, Inc. Cannula with associated filter
US5855597A (en) * 1997-05-07 1999-01-05 Iowa-India Investments Co. Limited Stent valve and stent graft for percutaneous surgery
US5858238A (en) * 1996-03-08 1999-01-12 Baxter Research Medical, Inc. Salvage of autologous blood via selective membrane/sorption technologies
US5865791A (en) * 1995-06-07 1999-02-02 E.P. Technologies Inc. Atrial appendage stasis reduction procedure and devices
US5865802A (en) * 1988-07-22 1999-02-02 Yoon; Inbae Expandable multifunctional instruments for creating spaces at obstructed sites endoscopically
US5868708A (en) * 1997-05-07 1999-02-09 Applied Medical Resources Corporation Balloon catheter apparatus and method
US5873894A (en) * 1998-02-17 1999-02-23 Sulzer Intermedics Inc. Diagnostic test protocol in an implantable medical device
US5876367A (en) * 1996-12-05 1999-03-02 Embol-X, Inc. Cerebral protection during carotid endarterectomy and downstream vascular protection during other surgeries
US5882340A (en) * 1992-04-15 1999-03-16 Yoon; Inbae Penetrating instrument having an expandable anchoring portion for triggering protrusion of a safety member and/or retraction of a penetrating member
US5885258A (en) * 1996-02-23 1999-03-23 Memory Medical Systems, Inc. Medical instrument with slotted memory metal tube
US5891178A (en) * 1996-05-14 1999-04-06 Pacesetter, Inc. Programmer system and associated methods for rapidly evaluating and programming an implanted cardiac device
US5895399A (en) * 1996-07-17 1999-04-20 Embol-X Inc. Atherectomy device having trapping and excising means for removal of plaque from the aorta and other arteries
US5904680A (en) * 1992-09-25 1999-05-18 Ep Technologies, Inc. Multiple electrode support structures having optimal bio-mechanical characteristics
US5904703A (en) * 1996-05-08 1999-05-18 Bard Connaught Occluder device formed from an open cell foam material
US5906207A (en) * 1996-04-04 1999-05-25 Merck & Co., Inc. Method for simulating heart failure
US5910154A (en) * 1997-05-08 1999-06-08 Embol-X, Inc. Percutaneous catheter and guidewire having filter and medical device deployment
US5916236A (en) * 1989-05-29 1999-06-29 Kensey Nash Corporation Occlusion assembly for sealing openings in blood vessels and a method for sealing openings in blood vessels
US6010531A (en) * 1993-02-22 2000-01-04 Heartport, Inc. Less-invasive devices and methods for cardiac valve surgery
US6010517A (en) * 1996-04-10 2000-01-04 Baccaro; Jorge Alberto Device for occluding abnormal vessel communications
US6024756A (en) * 1996-03-22 2000-02-15 Scimed Life Systems, Inc. Method of reversibly closing a septal defect
US6024755A (en) * 1998-12-11 2000-02-15 Embol-X, Inc. Suture-free clamp and sealing port and methods of use
US6033420A (en) * 1998-09-02 2000-03-07 Embol-X, Inc. Trocar introducer system and methods of use
US6036720A (en) * 1997-12-15 2000-03-14 Target Therapeutics, Inc. Sheet metal aneurysm neck bridge
US6048331A (en) * 1996-05-14 2000-04-11 Embol-X, Inc. Cardioplegia occluder
US6051014A (en) * 1998-10-13 2000-04-18 Embol-X, Inc. Percutaneous filtration catheter for valve repair surgery and methods of use
US6051015A (en) * 1997-05-08 2000-04-18 Embol-X, Inc. Modular filter with delivery system
US6056720A (en) * 1998-11-24 2000-05-02 Embol-X, Inc. Occlusion cannula and methods of use
US6059745A (en) * 1997-05-20 2000-05-09 Gelbfish; Gary A. Thrombectomy device and associated method
US6063070A (en) * 1997-08-05 2000-05-16 Target Therapeutics, Inc. Detachable aneurysm neck bridge (II)
US6068621A (en) * 1998-11-20 2000-05-30 Embol X, Inc. Articulating cannula
US6080183A (en) * 1998-11-24 2000-06-27 Embol-X, Inc. Sutureless vessel plug and methods of use
US6080182A (en) * 1996-12-20 2000-06-27 Gore Enterprise Holdings, Inc. Self-expanding defect closure device and method of making and using
US6079414A (en) * 1993-02-22 2000-06-27 Heartport, Inc. Method for thoracoscopic intracardiac procedures including septal defect
US6178351B1 (en) * 1996-08-19 2001-01-23 The Mower Family Chf Treatment Irrevocable Trust Atrial sensing and multiple site stimulation as intervention means for atrial fibrillation
US6235044B1 (en) * 1999-08-04 2001-05-22 Scimed Life Systems, Inc. Percutaneous catheter and guidewire for filtering during ablation of mycardial or vascular tissue
US20020022860A1 (en) * 2000-08-18 2002-02-21 Borillo Thomas E. Expandable implant devices for filtering blood flow from atrial appendages
US20020035374A1 (en) * 2000-09-21 2002-03-21 Borillo Thomas E. Apparatus for implanting devices in atrial appendages
US20030023266A1 (en) * 2001-07-19 2003-01-30 Borillo Thomas E. Individually customized atrial appendage implant device
US20030023262A1 (en) * 2001-07-18 2003-01-30 Jeffrey Welch Cardiac implant device tether system and method
US20030057156A1 (en) * 2001-03-08 2003-03-27 Dean Peterson Atrial filter implants
US6551303B1 (en) * 1999-10-27 2003-04-22 Atritech, Inc. Barrier device for ostium of left atrial appendage

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3844302A (en) 1970-09-14 1974-10-29 Telesco Brophey Ltd Collapsible umbrella
US4603693A (en) 1977-05-26 1986-08-05 United States Surgical Corporation Instrument for circular surgical stapling of hollow body organs and disposable cartridge therefor
US4166470A (en) 1977-10-17 1979-09-04 Medtronic, Inc. Externally controlled and powered cardiac stimulating apparatus
US4710192A (en) 1985-12-30 1987-12-01 Liotta Domingo S Diaphragm and method for occlusion of the descending thoracic aorta
US5037810A (en) 1987-03-17 1991-08-06 Saliba Jr Michael J Medical application for heparin and related molecules
FR2632864B2 (en) 1987-12-31 1990-10-19 Biomat Sarl filtering system for anti-embolic elastic vena cava and all means for its implementation
WO1989006551A1 (en) 1988-01-12 1989-07-27 Kievsky Nauchno-Issledovatelsky Institut Neirokhir Occluding device
DE8904371U1 (en) 1989-04-07 1989-06-08 Herzberg, Wolfgang, Dr. Med., 2000 Wedel, De
US5041093A (en) 1990-01-31 1991-08-20 Boston Scientific Corp. Catheter with foraminous anchor
CA2057018C (en) 1990-04-02 1997-12-09 Kanji Inoue Device for nonoperatively occluding a defect
US5234403A (en) 1990-05-25 1993-08-10 Sumitomo Bakelite Co., Ltd. Blood collecting apparatus
US5064435A (en) 1990-06-28 1991-11-12 Schneider (Usa) Inc. Self-expanding prosthesis having stable axial length
US5042707A (en) 1990-10-16 1991-08-27 Taheri Syde A Intravascular stapler, and method of operating same
SE9101839L (en) 1991-06-14 1992-10-12 Ams Medinvent Sa Apparatus foer transluminal extraction or implantation of a stent and apparatus comprising such a device
CA2078530A1 (en) 1991-09-23 1993-03-24 Jay Erlebacher Percutaneous arterial puncture seal device and insertion tool therefore
US5256146A (en) 1991-10-11 1993-10-26 W. D. Ensminger Vascular catheterization system with catheter anchoring feature
EP0545091B1 (en) 1991-11-05 1999-07-07 The Children's Medical Center Corporation Occluder for repair of cardiac and vascular defects
US5282827A (en) * 1991-11-08 1994-02-01 Kensey Nash Corporation Hemostatic puncture closure system and method of use
US5258042A (en) 1991-12-16 1993-11-02 Henry Ford Health System Intravascular hydrogel implant
JP3393383B2 (en) 1992-01-21 2003-04-07 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ Septal defect closure device
US5536412A (en) 1992-02-06 1996-07-16 Hemocleanse, Inc. Hemofiltration and plasmafiltration devices and methods
FR2689388B1 (en) 1992-04-07 1999-07-16 Celsa Lg blood filter perfects possibly resorbable.
US5766246A (en) 1992-05-20 1998-06-16 C. R. Bard, Inc. Implantable prosthesis and method and apparatus for loading and delivering an implantable prothesis
US5469867A (en) 1992-09-02 1995-11-28 Landec Corporation Cast-in place thermoplastic channel occluder
US5368034A (en) 1992-09-04 1994-11-29 Boston Scientific Corporation Method and apparatus for thrombolytic therapy
FR2696092B1 (en) 1992-09-28 1994-12-30 Lefebvre Jean Marie Kit for medical use consisting of a filter and its implementation device in the vessel.
DE669839T1 (en) * 1992-10-01 1996-10-10 Cardiac Pacemakers Inc Stent-like structure for entflimmerungselektroden.
US5382259A (en) 1992-10-26 1995-01-17 Target Therapeutics, Inc. Vasoocclusion coil with attached tubular woven or braided fibrous covering
US5443454A (en) 1992-12-09 1995-08-22 Terumo Kabushiki Kaisha Catheter for embolectomy
US5353784A (en) 1993-04-02 1994-10-11 The Research Foundation Of Suny Endoscopic device and method of use
US5417708A (en) 1994-03-09 1995-05-23 Cook Incorporated Intravascular treatment system and percutaneous release mechanism therefor
US5458574A (en) 1994-03-16 1995-10-17 Heartport, Inc. System for performing a cardiac procedure
US5846261A (en) * 1994-07-08 1998-12-08 Aga Medical Corp. Percutaneous catheter directed occlusion devices
US5433727A (en) 1994-08-16 1995-07-18 Sideris; Eleftherios B. Centering buttoned device for the occlusion of large defects for occluding
US5702421A (en) 1995-01-11 1997-12-30 Schneidt; Bernhard Closure device for closing a vascular opening, such as patent ductus arteriosus
US5690671A (en) 1994-12-13 1997-11-25 Micro Interventional Systems, Inc. Embolic elements and methods and apparatus for their delivery
US5643292A (en) 1995-01-10 1997-07-01 Applied Medical Resources Corporation Percutaneous suturing device
US5681347A (en) 1995-05-23 1997-10-28 Boston Scientific Corporation Vena cava filter delivery system
US5827229A (en) 1995-05-24 1998-10-27 Boston Scientific Corporation Northwest Technology Center, Inc. Percutaneous aspiration thrombectomy catheter system
US5849005A (en) * 1995-06-07 1998-12-15 Heartport, Inc. Method and apparatus for minimizing the risk of air embolism when performing a procedure in a patient's thoracic cavity
DE19548658A1 (en) 1995-12-18 1997-06-19 Biotronik Mess & Therapieg Extracorporeal control unit for an implantable medical device
NL1002423C2 (en) 1996-02-22 1997-08-25 Cordis Europ Temporary filter catheter.
US5830228A (en) 1996-05-29 1998-11-03 Urosurge, Inc. Methods and systems for deployment of a detachable balloon at a target site in vivo
US5669933A (en) 1996-07-17 1997-09-23 Nitinol Medical Technologies, Inc. Removable embolus blood clot filter
US5823198A (en) 1996-07-31 1998-10-20 Micro Therapeutics, Inc. Method and apparatus for intravasculer embolization
US5941249A (en) * 1996-09-05 1999-08-24 Maynard; Ronald S. Distributed activator for a two-dimensional shape memory alloy
US5776097A (en) 1996-12-19 1998-07-07 University Of California At Los Angeles Method and device for treating intracranial vascular aneurysms
US5782860A (en) 1997-02-11 1998-07-21 Biointerventional Corporation Closure device for percutaneous occlusion of puncture sites and tracts in the human body and method
US5800457A (en) 1997-03-05 1998-09-01 Gelbfish; Gary A. Intravascular filter and associated methodology
US5851232A (en) * 1997-03-15 1998-12-22 Lois; William A. Venous stent
US5800454A (en) 1997-03-17 1998-09-01 Sarcos, Inc. Catheter deliverable coiled wire thromboginic apparatus and method
US5836913A (en) 1997-05-02 1998-11-17 Innerdyne, Inc. Device and method for accessing a body cavity
US5928260A (en) * 1997-07-10 1999-07-27 Scimed Life Systems, Inc. Removable occlusion system for aneurysm neck
US5928192A (en) * 1997-07-24 1999-07-27 Embol-X, Inc. Arterial aspiration
US5935148A (en) * 1998-06-24 1999-08-10 Target Therapeutics, Inc. Detachable, varying flexibility, aneurysm neck bridge
US6689150B1 (en) * 1999-10-27 2004-02-10 Atritech, Inc. Filter apparatus for ostium of left atrial appendage

Patent Citations (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US178283A (en) * 1876-06-06 Improvement in vaginal syringes
US1967318A (en) * 1931-10-02 1934-07-24 Monahan William Apparatus for the treatment of the urethra
US3946731A (en) * 1971-01-20 1976-03-30 Lichtenstein Eric Stefan Apparatus for extracorporeal treatment of blood
US3874388A (en) * 1973-02-12 1975-04-01 Ochsner Med Found Alton Shunt defect closure system
US4007743A (en) * 1975-10-20 1977-02-15 American Hospital Supply Corporation Opening mechanism for umbrella-like intravascular shunt defect closure device
US4341218A (en) * 1978-05-30 1982-07-27 University Of California Detachable balloon catheter
US4934383A (en) * 1982-04-23 1990-06-19 George Glumac Electrode
US4585000A (en) * 1983-09-28 1986-04-29 Cordis Corporation Expandable device for treating intravascular stenosis
US4665906A (en) * 1983-10-14 1987-05-19 Raychem Corporation Medical devices incorporating sim alloy elements
US4817600A (en) * 1987-05-22 1989-04-04 Medi-Tech, Inc. Implantable filter
US4832055A (en) * 1988-07-08 1989-05-23 Palestrant Aubrey M Mechanically locking blood clot filter
US5865802A (en) * 1988-07-22 1999-02-02 Yoon; Inbae Expandable multifunctional instruments for creating spaces at obstructed sites endoscopically
US4921484A (en) * 1988-07-25 1990-05-01 Cordis Corporation Mesh balloon catheter device
US4917089A (en) * 1988-08-29 1990-04-17 Sideris Eleftherios B Buttoned device for the transvenous occlusion of intracardiac defects
US5192301A (en) * 1989-01-17 1993-03-09 Nippon Zeon Co., Ltd. Closing plug of a defect for medical use and a closing plug device utilizing it
US5916236A (en) * 1989-05-29 1999-06-29 Kensey Nash Corporation Occlusion assembly for sealing openings in blood vessels and a method for sealing openings in blood vessels
US5421832A (en) * 1989-12-13 1995-06-06 Lefebvre; Jean-Marie Filter-catheter and method of manufacturing same
US5078736A (en) * 1990-05-04 1992-01-07 Interventional Thermodynamics, Inc. Method and apparatus for maintaining patency in the body passages
US5279546A (en) * 1990-06-27 1994-01-18 Lake Region Manufacturing Company, Inc. Thrombolysis catheter system
US5329942A (en) * 1990-08-14 1994-07-19 Cook, Incorporated Method for filtering blood in a blood vessel of a patient
US5108420A (en) * 1991-02-01 1992-04-28 Temple University Aperture occlusion device
US5425744A (en) * 1991-11-05 1995-06-20 C. R. Bard, Inc. Occluder for repair of cardiac and vascular defects
US5176692A (en) * 1991-12-09 1993-01-05 Wilk Peter J Method and surgical instrument for repairing hernia
US5626605A (en) * 1991-12-30 1997-05-06 Scimed Life Systems, Inc. Thrombosis filter
US5411535A (en) * 1992-03-03 1995-05-02 Terumo Kabushiki Kaisha Cardiac pacemaker using wireless transmission
US5882340A (en) * 1992-04-15 1999-03-16 Yoon; Inbae Penetrating instrument having an expandable anchoring portion for triggering protrusion of a safety member and/or retraction of a penetrating member
US5637097A (en) * 1992-04-15 1997-06-10 Yoon; Inbae Penetrating instrument having an expandable anchoring portion
US5527338A (en) * 1992-09-02 1996-06-18 Board Of Regents, The University Of Texas System Intravascular device
US5904680A (en) * 1992-09-25 1999-05-18 Ep Technologies, Inc. Multiple electrode support structures having optimal bio-mechanical characteristics
US5417699A (en) * 1992-12-10 1995-05-23 Perclose Incorporated Device and method for the percutaneous suturing of a vascular puncture site
US5284488A (en) * 1992-12-23 1994-02-08 Sideris Eleftherios B Adjustable devices for the occlusion of cardiac defects
US5314451A (en) * 1993-01-15 1994-05-24 Medtronic, Inc. Replaceable battery for implantable medical device
US5735290A (en) * 1993-02-22 1998-04-07 Heartport, Inc. Methods and systems for performing thoracoscopic coronary bypass and other procedures
US6010531A (en) * 1993-02-22 2000-01-04 Heartport, Inc. Less-invasive devices and methods for cardiac valve surgery
US6079414A (en) * 1993-02-22 2000-06-27 Heartport, Inc. Method for thoracoscopic intracardiac procedures including septal defect
US5306234A (en) * 1993-03-23 1994-04-26 Johnson W Dudley Method for closing an atrial appendage
US5607579A (en) * 1993-04-27 1997-03-04 Haemonetics Corporation Apheresis apparatus for separating an intermediate density component from whole blood
US5380299A (en) * 1993-08-30 1995-01-10 Med Institute, Inc. Thrombolytic treated intravascular medical device
US5527322A (en) * 1993-11-08 1996-06-18 Perclose, Inc. Device and method for suturing of internal puncture sites
US5490856A (en) * 1993-12-14 1996-02-13 Untied States Surgical Corporation Purse string stapler
US5591196A (en) * 1994-02-10 1997-01-07 Endovascular Systems, Inc. Method for deployment of radially expandable stents
US5634942A (en) * 1994-04-21 1997-06-03 B. Braun Celsa Assembly comprising a blood filter for temporary or definitive use and a device for implanting it
US5522836A (en) * 1994-06-27 1996-06-04 Target Therapeutics, Inc. Electrolytically severable coil assembly with movable detachment point
US5725552A (en) * 1994-07-08 1998-03-10 Aga Medical Corporation Percutaneous catheter directed intravascular occlusion devices
US5713849A (en) * 1994-07-19 1998-02-03 Cordis Corporation Suction catheter and method
US5746767A (en) * 1994-10-25 1998-05-05 Scimed Life Systems, Inc. Removable thrombus filter
US5601595A (en) * 1994-10-25 1997-02-11 Scimed Life Systems, Inc. Remobable thrombus filter
US5614204A (en) * 1995-01-23 1997-03-25 The Regents Of The University Of California Angiographic vascular occlusion agents and a method for hemostatic occlusion
US5634936A (en) * 1995-02-06 1997-06-03 Scimed Life Systems, Inc. Device for closing a septal defect
US5766219A (en) * 1995-04-20 1998-06-16 Musc Foundation For Research Development Anatomically shaped vasoocclusive device and method for deploying same
US5865791A (en) * 1995-06-07 1999-02-02 E.P. Technologies Inc. Atrial appendage stasis reduction procedure and devices
US5709224A (en) * 1995-06-07 1998-01-20 Radiotherapeutics Corporation Method and device for permanent vessel occlusion
US5725568A (en) * 1995-06-27 1998-03-10 Scimed Life Systems, Inc. Method and device for recanalizing and grafting arteries
US5749883A (en) * 1995-08-30 1998-05-12 Halpern; David Marcos Medical instrument
US5709707A (en) * 1995-10-30 1998-01-20 Children's Medical Center Corporation Self-centering umbrella-type septal closure device
US5769816A (en) * 1995-11-07 1998-06-23 Embol-X, Inc. Cannula with associated filter
US5749894A (en) * 1996-01-18 1998-05-12 Target Therapeutics, Inc. Aneurysm closure method
US6024754A (en) * 1996-01-18 2000-02-15 Target Therapeutics Inc. Aneurysm closure method
US5885258A (en) * 1996-02-23 1999-03-23 Memory Medical Systems, Inc. Medical instrument with slotted memory metal tube
US5733294A (en) * 1996-02-28 1998-03-31 B. Braun Medical, Inc. Self expanding cardiovascular occlusion device, method of using and method of making the same
US5858238A (en) * 1996-03-08 1999-01-12 Baxter Research Medical, Inc. Salvage of autologous blood via selective membrane/sorption technologies
US6024756A (en) * 1996-03-22 2000-02-15 Scimed Life Systems, Inc. Method of reversibly closing a septal defect
US5906207A (en) * 1996-04-04 1999-05-25 Merck & Co., Inc. Method for simulating heart failure
US6010517A (en) * 1996-04-10 2000-01-04 Baccaro; Jorge Alberto Device for occluding abnormal vessel communications
US5904703A (en) * 1996-05-08 1999-05-18 Bard Connaught Occluder device formed from an open cell foam material
US5891178A (en) * 1996-05-14 1999-04-06 Pacesetter, Inc. Programmer system and associated methods for rapidly evaluating and programming an implanted cardiac device
US6048331A (en) * 1996-05-14 2000-04-11 Embol-X, Inc. Cardioplegia occluder
US6010522A (en) * 1996-07-17 2000-01-04 Embol-X, Inc. Atherectomy device having trapping and excising means for removal of plaque from the aorta and other arteries
US5895399A (en) * 1996-07-17 1999-04-20 Embol-X Inc. Atherectomy device having trapping and excising means for removal of plaque from the aorta and other arteries
US6178351B1 (en) * 1996-08-19 2001-01-23 The Mower Family Chf Treatment Irrevocable Trust Atrial sensing and multiple site stimulation as intervention means for atrial fibrillation
US5876367A (en) * 1996-12-05 1999-03-02 Embol-X, Inc. Cerebral protection during carotid endarterectomy and downstream vascular protection during other surgeries
US6074357A (en) * 1996-12-05 2000-06-13 Embol-X, Inc. Cerebral protection during carotid endarterectomy and downstream vascular protection during other surgeries
US6080182A (en) * 1996-12-20 2000-06-27 Gore Enterprise Holdings, Inc. Self-expanding defect closure device and method of making and using
US5855597A (en) * 1997-05-07 1999-01-05 Iowa-India Investments Co. Limited Stent valve and stent graft for percutaneous surgery
US5868708A (en) * 1997-05-07 1999-02-09 Applied Medical Resources Corporation Balloon catheter apparatus and method
US5911734A (en) * 1997-05-08 1999-06-15 Embol-X, Inc. Percutaneous catheter and guidewire having filter and medical device deployment capabilities
US5910154A (en) * 1997-05-08 1999-06-08 Embol-X, Inc. Percutaneous catheter and guidewire having filter and medical device deployment
US6027520A (en) * 1997-05-08 2000-02-22 Embol-X, Inc. Percutaneous catheter and guidewire having filter and medical device deployment capabilities
US6042598A (en) * 1997-05-08 2000-03-28 Embol-X Inc. Method of protecting a patient from embolization during cardiac surgery
US6051015A (en) * 1997-05-08 2000-04-18 Embol-X, Inc. Modular filter with delivery system
US6059745A (en) * 1997-05-20 2000-05-09 Gelbfish; Gary A. Thrombectomy device and associated method
US6063070A (en) * 1997-08-05 2000-05-16 Target Therapeutics, Inc. Detachable aneurysm neck bridge (II)
US6036720A (en) * 1997-12-15 2000-03-14 Target Therapeutics, Inc. Sheet metal aneurysm neck bridge
US5873894A (en) * 1998-02-17 1999-02-23 Sulzer Intermedics Inc. Diagnostic test protocol in an implantable medical device
US6033420A (en) * 1998-09-02 2000-03-07 Embol-X, Inc. Trocar introducer system and methods of use
US6051014A (en) * 1998-10-13 2000-04-18 Embol-X, Inc. Percutaneous filtration catheter for valve repair surgery and methods of use
US6068621A (en) * 1998-11-20 2000-05-30 Embol X, Inc. Articulating cannula
US6080183A (en) * 1998-11-24 2000-06-27 Embol-X, Inc. Sutureless vessel plug and methods of use
US6056720A (en) * 1998-11-24 2000-05-02 Embol-X, Inc. Occlusion cannula and methods of use
US6024755A (en) * 1998-12-11 2000-02-15 Embol-X, Inc. Suture-free clamp and sealing port and methods of use
US6235044B1 (en) * 1999-08-04 2001-05-22 Scimed Life Systems, Inc. Percutaneous catheter and guidewire for filtering during ablation of mycardial or vascular tissue
US20010005789A1 (en) * 1999-08-04 2001-06-28 Embol-X, Inc. Percutaneous catheter and guidewire for filtering during ablation of myocardial or vascular tissue
US20030120337A1 (en) * 1999-10-27 2003-06-26 Atritech, Inc. Barrier device for ostium of left atrial appendage
US6551303B1 (en) * 1999-10-27 2003-04-22 Atritech, Inc. Barrier device for ostium of left atrial appendage
US20020022860A1 (en) * 2000-08-18 2002-02-21 Borillo Thomas E. Expandable implant devices for filtering blood flow from atrial appendages
US20020035374A1 (en) * 2000-09-21 2002-03-21 Borillo Thomas E. Apparatus for implanting devices in atrial appendages
US20030057156A1 (en) * 2001-03-08 2003-03-27 Dean Peterson Atrial filter implants
US20030023262A1 (en) * 2001-07-18 2003-01-30 Jeffrey Welch Cardiac implant device tether system and method
US20030023266A1 (en) * 2001-07-19 2003-01-30 Borillo Thomas E. Individually customized atrial appendage implant device

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9345460B2 (en) 2001-04-24 2016-05-24 Cardiovascular Technologies, Inc. Tissue closure devices, device and systems for delivery, kits and methods therefor
US20090143808A1 (en) * 2001-04-24 2009-06-04 Houser Russell A Guided Tissue Cutting Device, Method of Use and Kits Therefor
US8518063B2 (en) 2001-04-24 2013-08-27 Russell A. Houser Arteriotomy closure devices and techniques
US8992567B1 (en) 2001-04-24 2015-03-31 Cardiovascular Technologies Inc. Compressible, deformable, or deflectable tissue closure devices and method of manufacture
US20090005777A1 (en) * 2001-04-24 2009-01-01 Vascular Closure Systems, Inc. Arteriotomy closure devices and techniques
US20090143789A1 (en) * 2007-12-03 2009-06-04 Houser Russell A Vascular closure devices, systems, and methods of use
US8961541B2 (en) 2007-12-03 2015-02-24 Cardio Vascular Technologies Inc. Vascular closure devices, systems, and methods of use
WO2012109297A3 (en) * 2011-02-10 2012-11-01 Atrial Innovations, Inc. Atrial appendage occlusion and arrhythmia treatment
US9295393B2 (en) 2012-11-09 2016-03-29 Elwha Llc Embolism deflector
US9414752B2 (en) 2012-11-09 2016-08-16 Elwha Llc Embolism deflector
US9526522B2 (en) 2013-09-27 2016-12-27 Medtronic, Inc. Interventional medical systems, tools, and assemblies
US10300286B2 (en) 2013-09-27 2019-05-28 Medtronic, Inc. Tools and assemblies thereof for implantable medical devices
US9675798B2 (en) 2014-08-26 2017-06-13 Medtronic, Inc. Interventional medical systems, devices, and components thereof
US10143823B2 (en) 2016-04-29 2018-12-04 Medtronic, Inc. Interventional medical systems and improved assemblies thereof and associated methods of use

Also Published As

Publication number Publication date
EP1392394A4 (en) 2005-05-18
WO2002098282A2 (en) 2002-12-12
EP1392394A2 (en) 2004-03-03
US6941169B2 (en) 2005-09-06
US20020183823A1 (en) 2002-12-05
JP2005508208A (en) 2005-03-31
WO2002098282A3 (en) 2003-05-01
CA2449468A1 (en) 2002-12-12

Similar Documents

Publication Publication Date Title
US7076296B2 (en) Method of supplying energy to subcutaneous cardioverter-defibrillator and pacer
US6567697B1 (en) External defibrillator with electrical CPR assist
US6370427B1 (en) Method and apparatus for dual chamber bi-ventricular pacing and defibrillation
JP5047986B2 (en) Hemodynamically controlled anti-tachyarrhythmia pacing system
US5205283A (en) Method and apparatus for tachyarrhythmia detection and treatment
US5476498A (en) Coronary sinus channel lead and method
US5002052A (en) System and method for detection and treatment of ventricular arrhythmias
US6556872B2 (en) Therapeutic device and method for treating diseases of cardiac muscle
US8290600B2 (en) Electrical stimulation of body tissue using interconnected electrode assemblies
Lindsay et al. Therapeutic end points for the treatment of atrioventricular node reentrant tachycardia by catheter-guided radiofrequency current
JP5170705B2 (en) Myocardium conditioning the use of myocardial stimulation and parasympathetic stimulation
US10022538B2 (en) Cardiac stimulation system
US5897586A (en) Implantable defibrillator lead
US5431685A (en) Implantable medical interventional device with criteria modification to enhance recognition of Tachycardia
US4787389A (en) Using an implantable antitachycardia defibrillator circuit
AU656420B2 (en) Method and apparatus for wide area antitachycardia pacing
US6094596A (en) Transvenous defibrillation lead system for use in middle cardiac vein
US5873897A (en) Method and apparatus for dual chambered tachyarrhythmia classification and therapy
US6539257B1 (en) Method and apparatus for treating cardiac arrhythmia
US8670842B1 (en) Intra-cardiac implantable medical device
US9956401B2 (en) Cardiac stimulation using intravascularly-deliverable electrode assemblies
US6351670B1 (en) Electrical cardiac assist for an implantable syncope monitor
US6757561B2 (en) Methods and apparatus for treating fibrillation and creating defibrillation waveforms
EP2081643B1 (en) System for neurally-mediated anti-arrhythmic therapy
US5683429A (en) Method and apparatus for cardiac pacing to prevent atrial fibrillation

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION